Bulasa, Prince Jhay A.
HRN: 23-76-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2025
MUPIROCIN 2%, 15G (TUBE)
01/18/2025
01/25/2025
TOPICAL
15g
TID
Phlebitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes